/

Sociétés

Ma

Non vérifié

Massive Bio

Ce que nous écrivons

IndustrieMédecine - DiversMultimédiaOncologieSanté

27 communiqués de presse

Voir tous les communiqués de presse

06/08/2026

Massive Bio Named an OpenAI Select Partner

Source

Émetteur

1.00

0

27/07/2026

Massive Bio and GELL Announce Strategic Partnership to Advance Research, Medical Education, and Artificial Intelligence Across Latin America and the United States

Source

Émetteur

1.00

0

20/07/2026

Massive Bio Partners With FOMAT to Expand Cancer Patient Prescreening for Clinical Trial Access

Source

Émetteur

1.00

0

13/07/2026

Massive Bio Announces Partnership with Sequence Me Now to Help Cancer Patients Access Clinical Trials

Source

Émetteur

1.00

0

03/06/2026

Massive Bio and Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage Non-Small Cell Lung Cancer Patients

Source

Émetteur

1.00

0

30/05/2026

Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026

Source

Émetteur

1.00

0

29/05/2026

Massive Bio Partners with TOUCH, The Black Breast Cancer Alliance and Navigating Trials to Expand Cancer Patients' Access to Clinical Trials

Source

Émetteur

1.00

0

28/05/2026

Massive Bio to Unveil Reticulum Nexus™ as the AI Operating System for Oncology Access at ASCO 2026

Source

Émetteur

1.00

0

21/05/2026

Massive Bio and BeeKeeperAI Deploy Federated Confidential Computing to Expand Oncology Trial Access Across Atlanta’s Underserved Communities

Source

Émetteur

1.00

0

14/05/2026

Massive Bio and Just Worldwide Announce Strategic Partnership to Connect More Cancer Patients to Clinical Trials

Source

Émetteur

1.00

0

Followers

0

Compatibilité

0